Schoch Charles 4
4 · Candel Therapeutics, Inc. · Filed Jan 17, 2025
Insider Transaction Report
Form 4
Schoch Charles
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-15$7.22/sh−9,511$68,717→ 43,038 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.